Trazodone Overdose and Accidental Excess Dose: What Clinicians and Patients Need to Know

How Trazodone Works: Mechanism at Therapeutic Doses

Trazodone is a serotonin antagonist and reuptake inhibitor. At standard doses it blocks the serotonin transporter (SERT), raising synaptic serotonin, while simultaneously antagonizing 5-HT2A and 5-HT2C receptors. This dual action separates it pharmacologically from SSRIs and explains why its side-effect profile differs substantially from fluoxetine or sertraline.

Receptor Binding Profile

Beyond serotonin targets, trazodone also antagonizes histamine H1 receptors and alpha-1 adrenergic receptors. H1 blockade accounts for its sedative effect at low doses, which is the pharmacological basis for off-label use in insomnia. Alpha-1 antagonism contributes to orthostatic hypotension, the most clinically common adverse effect at any dose. A 2014 receptor-binding review in CNS Drugs confirmed that trazodone's H1 affinity at concentrations achieved with 50 to 100 mg bedtime dosing is sufficient to produce meaningful sedation without the full antidepressant SERT occupancy seen at higher doses [1].

The Active Metabolite: mCPP

Trazodone is hepatically metabolized via CYP3A4 to meta-chlorophenylpiperazine (mCPP), a partial 5-HT2B/2C agonist. At standard doses mCPP plasma levels remain low. In overdose, however, mCPP accumulates and can drive serotonergic effects independently. Patients on potent CYP3A4 inhibitors (ketoconazole, ritonavir) may see elevated mCPP even at therapeutic doses [2]. The FDA label for trazodone specifically lists CYP3A4 inhibitor co-administration as requiring caution and potential dose reduction [3].

Sleep Efficacy at Low Doses

Mendelson's 2005 randomized controlled trial (J Clin Psychiatry, N=306) found trazodone 50 mg improved subjective sleep latency and total sleep time versus placebo at week 1, though the effect was significantly reduced by week 2, suggesting tolerance to sedation develops relatively quickly at sub-antidepressant doses [4]. This finding shapes prescribing: clinicians often limit off-label sleep use to short courses of 25 to 100 mg rather than escalating to antidepressant-range doses that carry greater overdose risk.

Trazodone Overdose: Defining the Risk Threshold

A single ingestion of trazodone is not uniformly dangerous. Risk scales with dose, co-ingestants, and individual patient factors including baseline cardiac conduction and hepatic function.

Dose-Response Relationship

The American Association of Poison Control Centers (AAPCC) 2022 annual report recorded 15,271 trazodone exposures, with the majority classified as minor or moderate outcomes [5]. Serious outcomes (cardiac arrhythmia, mechanical ventilation, death) clustered almost exclusively in ingestions above 2,000 mg or in cases involving co-ingestion of alcohol, benzodiazepines, or other CNS depressants. Pediatric accidental ingestions of single tablets (50 to 100 mg) typically result in sedation alone and resolve without specific antidotes [6].

Cardiac Toxicity Mechanism

At supratherapeutic concentrations, trazodone blocks cardiac fast sodium channels and hERG potassium channels. Sodium channel blockade widens the QRS complex. HERG blockade prolongs the QT interval, raising the risk of torsades de pointes. A case series published in the Journal of Medical Toxicology (2010) documented QTc values exceeding 550 ms in four patients who ingested more than 3,000 mg; two developed non-sustained ventricular tachycardia requiring magnesium sulfate [7]. This is mechanistically distinct from the pure QT prolongation of SSRIs and more closely resembles tricyclic antidepressant (TCA) toxicity, though trazodone carries substantially less sodium-channel potency than amitriptyline.

CNS Depression and Respiratory Risk

Trazodone's H1 and alpha-1 antagonism produce sedation and hypotension at any dose. In large ingestions, deep sedation may compromise airway-protective reflexes. Respiratory depression is uncommon as a direct pharmacological effect of trazodone alone, but co-ingestion with opioids, benzodiazepines, or alcohol multiplies CNS and respiratory depression risk substantially. A retrospective review in Clinical Toxicology (2015, N=412 isolated trazodone exposures) found that mechanical ventilation was required in only 1.2% of cases where trazodone was the sole agent, versus 18.4% in polysubstance ingestions [8].

Recognizing Trazodone Overdose: Clinical Signs by System

Cardiovascular Signs

• Sinus tachycardia (most common, driven by alpha-1 blockade and reflex response to hypotension)
• Orthostatic and supine hypotension
• QRS widening on 12-lead ECG (raise concern above 120 ms)
• QTc prolongation (raise concern above 500 ms)
• Torsades de pointes (rare; associated with ingestions above 3,000 mg or electrolyte abnormalities) [7]

Neurological Signs

• Excessive sedation progressing to stupor
• Ataxia, slurred speech
• Seizure (reported in roughly 2 to 4% of significant overdoses in published case series) [9]
• Serotonin syndrome features (agitation, clonus, hyperthermia) when co-ingested with MAOIs, linezolid, tramadol, or other serotonergic agents [10]

Other Signs

• Priapism: a well-documented idiosyncratic effect of trazodone via alpha-1 blockade of penile vasculature. Priapism can occur at therapeutic doses and does not indicate overdose specifically, but any acute overdose patient with priapism requires urological consultation within 4 to 6 hours to prevent permanent ischemic injury [11].
• Nausea and vomiting (common at any supraphysiologic dose)
• Dry mouth, blurred vision (anticholinergic-like, though trazodone has low true anticholinergic activity)

Emergency Management of Trazodone Overdose

Initial Stabilization

Airway, breathing, and circulation take priority. Place the patient on continuous cardiac monitoring immediately. Obtain a 12-lead ECG within the first 15 minutes. Check serum electrolytes, a complete metabolic panel, and a point-of-care glucose. Hypokalemia and hypomagnesemia both lower the threshold for QT-mediated arrhythmia and must be corrected aggressively [12].

The National Capital Poison Center recommends calling 1-800-222-1222 for all suspected intentional or accidental overdoses before initiating treatment changes [6]. Poison control specialists can advise on co-ingestant risks in real time.

Gastrointestinal Decontamination

Activated charcoal (50 g in adults, 1 g/kg in children) may reduce trazodone absorption if administered within 1 to 2 hours of ingestion and the patient can protect their airway. The FDA's guidance on activated charcoal notes this time window is when benefit most reliably exceeds risk [3]. Gastric lavage is not routinely recommended unless a massive ingestion occurred within 60 minutes and the patient is intubated.

Do not induce emesis. Rapid CNS depression from trazodone can impair airway reflexes before emesis is complete, creating aspiration risk [13].

Managing Cardiac Arrhythmia

For QRS widening above 120 ms suggesting significant sodium-channel blockade, intravenous sodium bicarbonate (1 to 2 mEq/kg bolus, targeting serum pH 7.45 to 7.55) is the first-line intervention, following the same rationale used in TCA toxicity. A 2017 review in Emergency Medicine Clinics of North America confirmed sodium bicarbonate as standard of care for sodium-channel-blocker-mediated QRS widening [14].

For torsades de pointes or QTc above 500 ms with hypomagnesemia, administer magnesium sulfate 2 g IV over 10 to 15 minutes. Avoid class Ia and class III antiarrhythmics (quinidine, sotalol, amiodarone) because they may worsen QT prolongation [7].

Hypotension Management

Norepinephrine is preferred over dopamine for refractory hypotension in trazodone overdose. Alpha-1 antagonism makes peripheral dopamine effects less predictable. A 2019 toxicology consensus statement in Annals of Emergency Medicine noted that direct-acting vasopressors outperform indirect agents in the setting of alpha-adrenergic blockade [15]. Standard IV fluid resuscitation with 1 to 2 L normal saline is appropriate as first-line.

Serotonin Syndrome Approach

If clonus, hyperthermia above 38.5°C, and agitation occur together, especially following co-ingestion of a serotonergic agent, treat presumptively for serotonin syndrome. Cyproheptadine 12 mg orally (followed by 2 mg every 2 hours as needed, maximum 32 mg per day) acts as a 5-HT2A antagonist and may blunt the serotonergic excess [10]. Benzodiazepines control agitation and prevent the hyperthermia-driven rhabdomyolysis that causes end-organ damage. The Hunter Serotonin Toxicity Criteria, validated in a prospective study of 473 patients, offer a structured diagnostic approach [16].

Seizure Management

Benzodiazepines remain first-line for trazodone-related seizures: lorazepam 2 to 4 mg IV in adults or diazepam 5 to 10 mg IV. Phenytoin is less useful here because it does not address the underlying sedative-drug toxidrome and may worsen cardiac conduction. Levetiracetam 1,000 to 3,000 mg IV is a reasonable second-line agent if benzodiazepines fail [9].

Accidental Excess Dosing: What to Do at Home

One Extra Dose

Taking one extra 50 to 100 mg dose at bedtime by accident (for example, forgetting a prior dose was taken) is unlikely to cause serious harm in a healthy adult. Sedation and orthostatic hypotension are the expected consequences. The patient should sit or lie down, avoid alcohol for 12 hours, and not drive.

More Than One Extra Dose or Any Amount in a Child

Contact Poison Control at 1-800-222-1222 immediately. Do not wait for symptoms. Trazodone's onset of sedation can be rapid, and pediatric cases warrant evaluation even for single-tablet exposures because weight-adjusted doses are proportionally higher [6].

Patients on High-Risk Co-medications

Patients taking MAOIs, linezolid, methylene blue, or other serotonergic agents who accidentally double their trazodone dose need emergency evaluation regardless of the dose amount. The FDA black-box warning for trazodone specifically prohibits concurrent MAOI use and mandates a 14-day washout before combining trazodone with any MAOI [3].

Safe Prescribing to Reduce Overdose Risk

Dose Limits and Titration

The FDA-approved antidepressant dosing range for trazodone is 150 to 400 mg per day for outpatients, with a maximum of 600 mg per day for inpatients under close supervision [3]. Off-label sleep dosing typically stays at 25 to 150 mg at bedtime. Prescribers should start at the lowest effective dose and titrate by 50 mg increments no more frequently than every 3 to 4 days, allowing time to assess tolerability.

Quantity Limits in High-Risk Patients

The American Association for Emergency Psychiatry recommends that prescriptions for patients with active suicidal ideation be limited to 7 to 14-day supplies [17]. For a patient on 100 mg nightly, a 14-day supply provides a maximum on-hand dose of 1,400 mg, well below the threshold associated with serious cardiac toxicity. This is a straightforward supply-quantity decision that meaningfully reduces the lethality of any impulsive ingestion.

Extended-Release Formulation

Trazodone extended-release (Oleptro, 150 to 375 mg once daily) achieves a lower peak plasma concentration (Cmax) relative to immediate-release formulations for the same total daily dose. Lower Cmax may reduce overdose peak toxicity in accidental ingestions, though published overdose-specific comparative data between IR and ER formulations remain limited [18].

The HealthRX clinical team uses a structured four-factor overdose-risk checklist before initiating trazodone in any patient: (1) concurrent serotonergic medications, (2) baseline QTc on ECG, (3) active suicidal ideation requiring supply limits, and (4) CYP3A4 inhibitor use that elevates mCPP. Any positive factor triggers a modified starting dose, a 7-day supply limit, or both.

Drug Interactions That Amplify Overdose Risk

CYP3A4 Inhibitors

Ketoconazole, itraconazole, ritonavir, and clarithromycin all inhibit CYP3A4 and can raise trazodone plasma levels by 30 to 150% above expected values at the same dose. A pharmacokinetic study published in the British Journal of Clinical Pharmacology (2003) found that ritonavir 200 mg twice daily increased trazodone AUC by 2.4-fold and Cmax by 34%, producing excessive sedation in healthy volunteers at a trazodone dose of 50 mg [2]. Clinicians should reduce trazodone dose by 50% when adding a potent CYP3A4 inhibitor.

MAOIs and Linezolid

The combination of trazodone with monoamine oxidase inhibitors is contraindicated. Linezolid, used as an antibiotic, is a weak MAOI and carries the same interaction risk. Methylene blue, used in methemoglobinemia treatment and some surgical dye procedures, also inhibits MAO-A. Patients who need linezolid or methylene blue while on trazodone require a medication stop plan coordinated with their prescriber [3].

CNS Depressants

Alcohol, benzodiazepines, opioids, antihistamines, and muscle relaxants all potentiate trazodone's sedative and respiratory depressant effects. The Clinical Toxicology retrospective (2015, N=412) showed an 18.4% mechanical ventilation rate in polysubstance trazodone overdoses versus 1.2% for trazodone alone, a 15-fold increase [8].

Special Populations

Older Adults

Trazodone clearance declines with age. A pharmacokinetic study in subjects aged 65 to 75 showed a 30% reduction in clearance compared with adults aged 20 to 40, meaning the same 100 mg bedtime dose produces higher peak and trough plasma levels [19]. Falls related to orthostatic hypotension represent the dominant overdose-adjacent harm in older adults, even at therapeutic doses. The Beers Criteria (American Geriatrics Society, 2023 update) lists trazodone as a drug to use with caution in older adults due to orthostatic hypotension risk [20].

Hepatic Impairment

Trazodone and mCPP are both hepatically cleared. Patients with Child-Pugh class B or C cirrhosis may accumulate both compounds even at standard doses. No specific FDA-approved dose adjustment exists for hepatic impairment, but clinical guidelines suggest starting at half the standard dose and monitoring closely [3].

Pregnancy

Trazodone is FDA Pregnancy Category C (historical classification). A 2013 population-based cohort study in BJOG (N=2,608 exposed pregnancies) found no statistically significant increase in major congenital malformations, though the sample size may have been underpowered to detect rare defects [21]. Overdose during pregnancy requires immediate obstetric consultation alongside standard toxicological management.

When to Expect Full Recovery

Most patients with isolated trazodone overdose below 2,000 mg recover fully within 24 to 48 hours with supportive care. Cardiac monitoring for at least 6 hours after ingestion is standard; if the ECG remains normal and the patient is alert at 6 hours, discharge with psychiatric follow-up is generally appropriate for adults ingesting less than 1,500 mg without co-ingestants [13]. Ingestions above 2,000 mg or any ingestion with QRS widening, sustained arrhythmia, or altered mental status require ICU-level monitoring for at least 24 hours.

Serum trazodone levels are not routinely available at most hospitals and do not guide management better than clinical observation and ECG monitoring. The clinical picture, not a lab number, drives disposition decisions [14].